Anti-Scl-70 (topo-I) antibodies in SLE: Myth or reality?

Autoimmunity Reviews

Volumn 9, Issue 11, 2010, Pages 756-760

  Mahler, Michael ^a   Silverman, Earl D ^b   Schulte Pelkum, Johannes ^a   Fritzler, Marvin J ^c  

^a Dr Fooke Laboratorien GmbH   (Germany)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Autoantibodies; Scl 70; SLE; Systemic lupus erythematosus; Systemic sclerosis; Topoisomerase I

Indexed keywords

AUTOANTIBODY; DNA TOPOISOMERASE; DOUBLE STRANDED DNA; DOUBLE STRANDED DNA ANTIBODY; SCL 70 ANTIBODY;

CHROMATIN; CLINICAL TRIAL; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; HUMAN; IMMUNOASSAY; META ANALYSIS; PREVALENCE; PROTEIN DNA BINDING; REVIEW; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; BIOLOGICAL MARKERS; CANADA; CHROMATIN; DNA TOPOISOMERASES, TYPE I; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SCLERODERMA, SYSTEMIC;

EID: 77956188883     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.06.005     Document Type: Review

References (41)

1. von Mühlen C.A., Tan E.M. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995, 24:323-358.
2. Ho K.T., Reveille J.D. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 2003, 5:80-93.
3. Mahler M., Raijmakers R. Novel aspects of autoantibodies to the PM/Scl complex: Clinical, genetic and diagnostic insights. Autoimmun Rev 2007, 6:432-437.
4. Schulte-Pelkum J., Fritzler M., Mahler M. Latest update on the Ro/SS-A autoantibody system. Autoimmun Rev 2007, 8:632-637.
5. Walker J.G., Fritzler M.J. Update on autoantibodies in systemic sclerosis. Curr Opin Rheumatol 2007, 19:580-591.
6. Hudson M., Fritzler M.J., Baron M. Systemic sclerosis: establishing diagnostic criteria. Medicine 2010, 89:159-165. (Baltimore).
7. Sherer Y., Gorstein A., Fritzler M.J., Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004, 34:501-537.
8. Sharp G.C., Hoffmann R.W. Overlap syndromes: mixed connective tissue disease and Sjögren's syndrome. Systemic lupus erythematosus 1999, 551-573. Academic Press, New York. R.G. Lathita (Ed.).
9. Czömpöly T., Simon D., Czirják L., Németh P. Anti-topoisomerase I autoantibodies in systemic sclerosis. Autoimmun Rev 2009, 8:692-696.
10. Stinton L.M., Fritzler M.J. A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders. Autoimmun Rev 2007, 7:77-84.
11. Ghirardello A., Bendo R., Rampudda M.E., Bassi N., Zampieri S., Doria A. Commercial blot assays in the diagnosis of systemic rheumatic diseases. Autoimmun Rev 2009, 8:645-649.
12. Fritzler M.J., Fritzler M.L. The emergence of multiplexed technologies as diagnostic platforms in systemic autoimmune diseases. Curr Med Chem 2006, 13:2503-2512.
13. Chan E.K., Fritzler M.J., Wiik A., Andrade L.E., Reeves W.H., Tincani A., et al. AutoAbSC. Org-Autoantibody Standardization Committee in 2006. Autoimmun Rev 2007, 6:577-580.
14. Dellavance A., Gallindo C., Soares M.G., da Silva N.P., Mortara R.A., Andrade L.E. Redefining the Scl-70 indirect immunofluorescence pattern: Autoantibodies to DNA topoisomerase I yield a specific compound immunofluorescence pattern. Rheumatology 2009, 48:632-637.
15. Stojanov L., Satoh M., Dooley M.A., Kuwana M., Jennette J.C., Reeves W.H. Autoantibodies to topoisomerase I in a patient with systemic lupus erythematosus without features of scleroderma. Lupus 1995, 4:314-317.
16. Kameda H., Kuwana M., Hama N., Kaburaki J., Homma M. Coexistence of serum anti-DNA topoisomerase I and anti-Sm antibodies: Report of 3 cases. J Rheumatol 1997, 24:400-403.
17. Koenig M., Joyal F., Fritzler M.J., Roussin A., Abrahamowicz M., Boire G., et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008, 58:3902-3912.
18. Dick T., Mierau R., Bartz-Bazzanella P., Alavi M., Stoyanova-Scholz M., Kindler J., et al. Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis. Ann Rheum Dis 2002, 61:121-127.
19. Gussin H.A., Ignat G.P., Varga J., Teodorescu M. Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 2001, 44:376-383.
20. Mahler M., Raijmakers R., Fritzler M.J. Challenges and controversies in autoantibodies associated with systemic rheumatic diseases. Curr Rheumatol Rev 2007, 3:67-78.
21. Mahler M., Raijmakers R., Dähnrich C., Blüthner M., Fritzler M.J. Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen. Arthritis Res Ther 2005, 7:R704-R713.
22. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
23. Radice A., Sinico R.A. A new oligonucleotide-based ELISA for the detection of anti-double-stranded DNA antibodies. Autoimmunity 2006, 39:113-119.
24. Hoffman I.E., Peene I., Meheus L., Huizinga T.W., Cebecauer L., Isenberg D., et al. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis 2004, 63:1155-1158.
25. Eissfeller P., Sticherling M., Scholz D., Hennig K., Lüttich T., Motz M., et al. Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases. Ann NY Acad Sci 2005, 1050:327-339.
26. Fritzler M.J., Behmanesh F., Fritzler M.L. Analysis of human sera that are polyreactive in an addressable laser bead immunoassay. Clin Immunol 2006, 120:349-356.
27. Shovman O., Gilburd B., Zandman-Goddard G., Yehiely A., Langevitz P., Shoenfeld Y. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases. Autoimmunity 2005, 38:105-109.
28. Zandman-Goddard G., Gilburd B., Shovman O., Blank M., Berdichevski S., Langevitz P., et al. The homogeneous multiplexed system-a new method for autoantibody profile in systemic lupus erythematosus. Clin Dev Immunol 2005, 12:107-111.
29. Hanly J.G., Thompson K., McCurdy G., Fougere L., Theriault C., Wilton K. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus. J Immunol Meth 2010, 352:147-152.
30. Hanly J.G., Su L., Farewell V., Fritzler M.J. Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus. J Immunol Meth 2010, 358:75-80.
31. Tang X., Huang Y., Deng W., Tang L., Weng W., Zhang X. Clinical and serologic correlations and autoantibody clusters in systemic lupus erythematosus: a retrospective review of 917 patients in South China. Medicine 2010, 89:62-67. (Baltimore).
32. Mahler M., Kessenbrock K., Raats J., Fritzler M.J. Technical and clinical evaluation of anti-ribosomal P protein immunoassays. J Clin Lab Anal 2004, 18:215-223.
33. Reveille J.D. Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus 2004, 13(5):290-297. Review.
34. Prestigiacomo T, Watkins M, Binder SR. Anti-topoisomerase I (anti-Scl70) autoantibodies are specific to scleroderma and are not present in patients with SLE. In from animal models to human genetics: Research on the induction and pathogenity of autoantibodies. Eds. Conrad K., Bachmann M.P., Chan E.K.L., Fritzler M.J., Humbel, Sack U., Shoenfeld Y. Page 365-8.
35. Hanke K, Dähnrich C, Brückner CS, Huscher D, Becker M, Jansen A, et al. Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort. Arthritis Res Ther 2009, 11:R28.
36. Biagini RE, Parks CG, Smith JP, Sammons DL, Robertson SA Analytical performance of the AtheNA MultiLyte ANA II assay in sera from lupus patients with multiple positive ANAs. Anal Bioanal Chem 2007, 388:613-618.
37. Martins TB, Burlingame R, von Mühlen CA, Jaskowski TD, Litwin CM, Hill HR Evaluation of multiplexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens. Clin Diagn Lab Immunol 2004, 11:1054-1059.
38. Hénault J., Tremblay M., Clément I., Raymond Y., Senécal J.L. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Arthritis Rheum 2004, 50:3265-3274.
39. Hénault J., Robitaille G., Senécal J.L., Raymond Y. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients. Arthritis Rheum 2006, 54:963-973.
40. Simon D., Czömpöly T., Berki T., Minier T., Peti A., Tóth E., et al. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus. Int Immunol 2009, 21:415-422.
41. Kessenbrock K., Raijmakers R., Fritzler M.J., Mahler M. Synthetic peptides: the future of patient management in systemic rheumatic diseases?. Curr Med Chem 2007, 14:2831-2838.